US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

676.82

-16.7285-2.41%

Number of Gainers:55

Number of Losers:90

Number of Flat:8

PE:- -

High:696.26

Open:693.57

Low:666.52

Close:693.55

Volume:386.44M

Turnover:11.23B

Market Cap:471.30B

Float Cap:357.32B

Loading ...

Allarity Therapeutics Granted Japanese Patent for Stenoparib DRP® Companion Diagnostic, Further Strengthening Stenoparib Development

Upexi to Host Fiscal Year 2026 Earnings Call on Thursday, September 17th at 5:30 P.M. ET

Intel, Sandisk, Palantir, Coinbase, and More Stocks That Explain Today's Market

Circle, Coinbase Fall Ahead Of Pivotal Procedural Vote On The CLARITY Act

Options & Short Sell

Vera Therapeutics Shares Gain on Positive Late-Stage Trial Results

Vera Therapeutics Reports Successful TRUTAKNA Phase 3 Results

Top Premarket Gainers

MT Newswires Live

Crypto Equities Slide Ahead of Pivotal Senate Vote on Market Structure Bill

Vera Therapeutics up 13% in pre-market at $38.63 after trutakna ORIGIN 3 data

Vera Therapeutics Gains After Kidney Disease Drug Meets Goals in Confirmatory Trial

Vera Therapeutics’ trutakna meets all efficacy endpoints in IgAN trial

Vera Therapeutics, - Trutakna Demonstrates Favorable Safety Profile Generally Comparable to Placebo

THOMSON REUTERS

Vera Therapeutics, - Plans to Submit Supplemental Bla to FDA for Full Approval in Q4 2026

THOMSON REUTERS

Vera Therapeutics Announces Trutakna™ (Atacicept-Vymj) Stabilized Egfr and Prevented Kidney Disease Progression Through Two Years in Origin 3 Final Efficacy Analysis in Iga Nephropathy

THOMSON REUTERS

Vera Therapeutics, - Trutakna Meets All Prespecified Endpoints in Origin 3 Final Efficacy Analysis

THOMSON REUTERS

Citi ups Acumen target, opens ‘upside 90-day catalyst watch’

AI Slowdown Debate Lifts Software Stocks as MNDY Jumps 10.7%

Agilon Health upgraded to Outperform from Market Perform at Bernstein

Zhihu Completes Share Buyback Worth $160,100 on September 14

Crypto-Linked Stocks Fall as Bitcoin Slides Ahead of Clarity Act Vote, Fed Decision

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/BK4539/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":676.82104,"timestamp":1789588799999,"preClose":693.54956,"halted":0,"volume":386442418,"delay":0,"changeRate":-0.02412,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-16.728516,"latestTime":"09-16 16:00:00 EDT","open":693.5709,"high":696.2584,"low":666.51996,"amount":11225464883.563019,"amplitude":0.042879,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.501072,"peRate":120.356726,"turnoverRate":0.030217,"increases":55,"decrements":90,"flats":5,"marketCap":471297965806,"floatMarketCap":357322768611.125},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":696.2584,"amplitude":0.042879,"preClose":693.54956,"low":666.51996,"pbRate":"5.501072","latestPrice":676.82104,"volume":386442418,"delay":0,"open":693.5709,"prevYearClose":881.5255,"prevWeekClose":693.0266,"prevMonthClose":701.0681,"prevQuarterClose":742.922,"fiveDayClose":690.0618,"twentyDayClose":655.4622,"sixtyDayClose":721.7143,"secType":"PLATE","market":"US","turnoverRate":0.030217,"peRate":120.356726,"marketCap":471297965806,"floatMarketCap":357322768611.125,"timestamp":1789588799999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":55,"down":90,"flat":8},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667564210","title":"Allarity Therapeutics Granted Japanese Patent for Stenoparib DRP® Companion Diagnostic, Further Strengthening Stenoparib Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2667564210","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667564210?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:00","pubTimestamp":1789473600,"startTime":"0","endTime":"0","summary":"TARPON SPRINGS, Fla., September 15, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/15/3362020/0/en/allarity-therapeutics-granted-japanese-patent-for-stenoparib-drp-companion-diagnostic-further-strengthening-stenoparib-development.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JPO","USRD","LENZ","BK4139","BK4007","ALLR","JPMO","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667175642","title":"Upexi to Host Fiscal Year 2026 Earnings Call on Thursday, September 17th at 5:30 P.M. ET","url":"https://stock-news.laohu8.com/highlight/detail?id=2667175642","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667175642?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:00","pubTimestamp":1789473600,"startTime":"0","endTime":"0","summary":"TAMPA, Fla., Sept.  15, 2026 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ: UPXI) (the “Company” or “Upexi”), a leading Solana-focused digital asset treasury company and consumer brands owner, today announc","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/15/3362019/0/en/upexi-to-host-fiscal-year-2026-earnings-call-on-thursday-september-17th-at-5-30-p-m-et.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PXIU","UPXI","BSOL","SSK","SOLZ","GSOL","SOLX","SLON","BK4539","SOLM","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667264170","title":"Intel, Sandisk, Palantir, Coinbase, and More Stocks That Explain Today's Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2667264170","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667264170?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:30","pubTimestamp":1789471800,"startTime":"0","endTime":"0","summary":"Stock futures were falling on Tuesday as a rally in oil prices drove the 10-Year Treasury yield to its highest level in more than 19 years.Chip and memory stocks were edging higher, having taken a battering on Monday after several top executives called for a slowdown in AI development. Coherent, Intel, Lumentum, Micron, and Sandisk all rose ahead of the opening bell.Shares of software developers were struggling as investors locked in some profit following the previous session's rally. CrowdStrike, Palantir, and Workday all slipped in premarket trading.Crypto exchange Coinbase dropped 4.1%, trading platform Robinhood declined 2.2%, and Bitcoin investor Strategy fell 3.5% as hopes of the Clarity Act passing this year faded. The Senate is set to vote on the crypto regulation bill on Tuesday afternoon.Shares of energy majors were rising as benchmark oil prices rallied. Halliburton added 1% and Occidental Petroleum climbed 0.8%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FIAT","IE00BJLML261.HKD","HK0000304797.USD","FINX","LU0640476718.USD","IEZ","CRWD","PSI","BK4613","LU2063271972.USD","COIO","PLTG","BUG","HOOX","MUZ","LU2764263203.CNY","BK4550","LU2125909247.SGD","BK4023","BK4533","LU1917777945.USD","LU2168564149.EUR","HOOI","LU0792757196.USD","BK4112","LU1548497426.USD","3LMI.UK","CHAT","GUNZ","HOYY","SPAM","IGV","LU0417517546.SGD","LU0353189763.USD","LU1923622614.USD","DRMY","HOOC","MU","LU2756315664.SGD","COWG","LU0985481810.HKD","IE00B894F039.SGD","SNXX","LEGR","SHLD","HOII","SNDQ","MUD","LU1868836914.USD","LU1803068979.SGD","LU2106854487.HKD","LU0672654240.SGD","AIQ","IBLC","LU0238689110.USD","LU1861220033.SGD","BK4528","FDIG","BK4605","TTXU","LU0061475181.USD","LU0820562030.AUD","LU1804176565.USD","IETC","HOOD","LU2168563687.JPY","LU0048573561.USD","LU2543165471.USD","LU0708995401.HKD","LU1868836591.USD","CGGO","LU2931357623.SGD","MSTY","LU1674673691.USD","IE00BK4W5L77.USD","BITQ","HAL","MSTK","PTF","LU0964807845.USD","IE00BZ9MQY76.HKD","QQQA","LU1989764664.SGD","LU1366333091.USD","LU2471134952.CNY","BK4596","WCBR","IE000F7OJYX1.SGD","IE0009356076.USD","MTYY","EYES","SOXX","TMSL","COIN","AIFD","IE00B1XK9C88.USD","LU0256863811.USD","LU1868837300.USD","LU1316542783.SGD","EGGY","BK4141","LU0889565833.HKD","PLTA","MSST","LU0719512351.SGD","PLTW","BKCH","LU2458330243.SGD","LU0225771236.USD","IE0000B7K699.USD","QQQG","IE00B19Z3581.USD","LU0820561909.HKD","IE00BSNM7G36.USD","LU1914381329.SGD","BK4588","MUU","BK4598","IAI","LU1852331112.SGD","OPTZ","PLYY","IE00B5949003.HKD","FDTX","SNDG","LU1720051108.HKD","MSTW","CONI","SGXZ51526630.SGD","PLTU","BK4553","IXN","CHPS","LU0320765059.SGD","LU0321505868.SGD","LU0889566641.SGD","PLTR","LU1720051017.SGD","LU2125909593.SGD","LU0203345920.USD","LU2023250330.USD","PSWD","LU2087625088.SGD","MUYY","OWNB","LU2244417387.USD","PLTL","BAI","FSMD","CHPX","IE00B19Z9P08.USD","LU2089985449.USD","LU0353189680.USD","FTXL","ICOI","USXF","TRFK","LU2764262908.HKD","LU2168564495.EUR","LU0787776722.HKD","SCHA","LU2148611432.USD","BK4547","HODU","HOOG","SPLTRmain","IE00BKDWB100.SGD","LU0742534661.SGD","APED","LU1923623000.USD","LU0306806265.USD","SGXZ99366536.SGD","LU0157215616.USD","LU1551013342.USD","LU2750360641.GBP","SNDK","BK4579","ROBN","LU0082616367.USD","CNAV","FCUS","INT","IE0002270589.USD","LU2458330169.SGD","LU2265009873.SGD","LU2403377893.USD","IE00BK4W5M84.HKD","09799","BK4532","SINTCmain","LU2471134796.USD","LU0256331488.USD","SMU00main","LU2048586759.USD","LU2264538146.SGD","IE000WAW04H5.SGD","CONY","IE00B7SZLL34.SGD","LU0251142724.SGD","SG9999001424.SGD","LU2360107671.USD","07399","OXY","LU0266013472.USD","BK4560","MSTR","CRPT","IE00B19Z3B42.SGD","MULL","PLTD","BK4566","09711","BK4127","MSII","BK4170","SGXZ81514606.USD","LU0203347892.USD","LU0210536198.USD","LU1989764748.USD","EMSF","LU1951198990.SGD","CONX","MSTY.UK","BK4515","FAI","PLTI","LU2125909759.SGD","WUGI","LMI3.UK","OIH","VGT","SMH","LU1280957306.USD","COII","LU0127658192.USD","HOOZ","IE000M9KFDE8.USD","LU2211815571.USD","LU2720916845.USD","LU2168564222.USD","BK4201","LU2360107168.USD","CRWL","FTEC","INYY","LU1323610961.USD","LU1868836757.USD","AIS","FXL","LU0154236417.USD","LU0642271901.SGD","LU2756315318.SGD","LU0097036916.USD","HBMX","BK4529","LU2360106780.USD","LU1145028129.USD","MSTU","SMST","HOOY","04335","LU2290526834.HKD","LU0133085943.USD","LU0689472784.USD","MST","LU1861215975.USD","LU0306807586.USD","LU1861217088.USD","SNDC","PLOO","LU2433249047.HKD","BK4527","PLTY","LU0081259029.USD","BK4612","IE00BWXC8680.SGD","LU0256863902.USD","LU1861558580.USD","LU0054578231.USD","LU0149725797.USD","BK4535","LU0251131958.USD","GB00BDT5M118.USD","LU1861559042.SGD","LU2896262040.SGD","LU0274383776.USD","LU1551013425.SGD","LU2054465674.USD","ARTY","CRWC","LU1674673428.USD","LU2102340556.USD","LU2250418816.HKD","IMST","MSOO","BK4551","LU1064131342.USD","07711","BK4559","LU2168564065.EUR","CIBR","LU2471134523.USD","LU2213496289.HKD","RULE","HOOW","COIG","BOBP","EFIV","BK4534","07311","BPAY","MIC","LU1868837136.USD","SOXQ","LU0943347566.SGD","BK4543","LU1992135399.USD","LU0820561818.USD","LU2286300806.USD","XLK","BK4585","LU2357627491.SGD","LU2471134879.HKD","XNTK","LU0096364046.USD","COIW","LU0187121727.USD","BK4575","SMI3.UK","BK4179","BK4554","LU1988902786.USD","JGRO","LU2357305700.SGD","MSTZ","BK4595","LU1861220207.SGD","LU1923622291.USD","COYY","LU0683600562.USD","IE000MB6IJN5.SGD","BK4539","CONL","IE000BZT7R73.USD","LU2272731600.USD","LU0321505439.SGD","MSTC","PXJ","LU1629891620.HKD","DISK","LU0234570918.USD","SNDU","LU0323591593.USD","DRIV","COIX","LU1951200564.SGD","LU2750360997.AUD","BK4097","PTIR","MSDD","PLTZ","LINT","BK4602","LU1267930730.SGD","LU2023250504.SGD","MSTX","BK4516","INTC","IE00B19Z9Z06.USD","WNTR","OILT","MSTP","LU2125909916.SGD","PLT","LU0109391861.USD","09311","IE000SO60NU8.SGD","LU0963586101.USD","MUG","LU2272731782.SGD","HK0000304805.HKD","09399","AIPI","IE0034235303.USD","INTW","BLCK","LU1974910355.USD","3SMI.UK","LU0056508442.USD","WLDR","COIA","LU1992135472.HKD","LU0859254822.USD","CLOD","LU0109392836.USD","LU2764263039.SGD","SCHM","LU1267930813.SGD","HAKY","LU0225284248.USD","LU1778281490.HKD","TTEQ","BK4600","07799","BK4512","SHOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187918678","title":"Circle, Coinbase Fall Ahead Of Pivotal Procedural Vote On The CLARITY Act","url":"https://stock-news.laohu8.com/highlight/detail?id=1187918678","media":"Options & Short Sell","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187918678?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:24","pubTimestamp":1789471494,"startTime":"0","endTime":"0","summary":"","market":"sg","thumbnail":"https://static.tigerbbs.com/0ad8caebd3441ecce1e384caee58aeed","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/0ad8caebd3441ecce1e384caee58aeed"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Circle, Coinbase Fall Ahead of Pivotal Procedural Vote on the CLARITY Act","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861217088.USD","NA","FIAT","CONY","BLSH","MTYY","TRON","SBET","ICRC","DEFT","MSTU","HUTG","BTCS","BK4023","HOOY","BTCT","CIFR","CIFU","CONI","CIFG","MARA","BNC","CEP","HOOW","HOYY","HUT","ROBN","SMST","CCUP","MSTC","ALTS","BKCH","BK4595","ETHM","BLSG","CONX","MSST","LU1668664300.SGD","COII","MSTY","LU1861220207.SGD","FINX","CRCG","APLX","MST","GEMI","RIOX","COYY","RIOT","IMST","RTYY","SOS","MSTW","WULF","BLCK","07711","BMNZ","07799","FDIG","IREN","LU1861559042.SGD","ICOI","COIN","BMNG","07311","ASST","MSTX","MSTK","LU0106831901.USD","HOII","MSII","IREX","BK4112","COIW","HOOG","CRPT","CRCO","BTM","BK4539","CONL","COIX","CIR","DFDV","FIGR","HODU","BK4588","STSS","09711","APLD","BK4585","MSTZ","YBMN","09311","EBON","CRCD","BMNR","LU2360107671.USD","MRAL","SQNS","MSTR","IBLC","GEMG","MHX","CRCA","LU1861558580.USD","CLSX","COIO","BK4554","BITQ","BK4551","NCTY","BMNU","HOOD","COIG","WULX","CLSK","SBTU","ETHZ","CAN","CRCL","07399","BK4600","IREZ","LU1791807156.HKD","CLSZ","HOOX","MSDD","BKKT","BNMC","HOOC","WNTR","IREC","HOOZ","IRE","BITF","UPXI","BLSX","FGRU","APLZ","BTBT","CIFC","COIA","ORBS","BK4535","BK4596","BK4516","IREG","IMRA","ABTC","MSTP","MAAY","MARO"],"isVideo":true,"video":{"duration":166,"video_url":"https://news-video-sg.skytigris.cn/videos/remotion/1656/render_1656_1789470774488.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/1656.webp","audio_url":"https://news-video-sg.skytigris.cn/videos/remotion/1656/tts/voiceover_d2c922086485ff4f.mp3","isAI":true},"gpt_icon":0},{"id":"2667641178","title":"Vera Therapeutics Shares Gain on Positive Late-Stage Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2667641178","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667641178?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:19","pubTimestamp":1789471140,"startTime":"0","endTime":"0","summary":"Shares of Vera Therapeutics climbed after the company said Trutakna, a treatment which helps mitigate the progression of certain kidney diseases, met all prespecified endpoints in a late-stage trial.The stock rose 9.8%, to $37.39, in premarket trading Tuesday. Through Monday's close, shares have lost roughly 30% of their value year to date.Vera before the bell said Trutakna achieved a statistically-significant reduction in risk of composite kidney disease progression, including proteinuria, or an excess of protein in urine.Trutakna was well tolerated, with a favorable safety profile generally comparable to placebo, the biotechnology company added. The treatment was tested in adult patients with primary IgA nephropathy at risk for disease progression.IgAN is a serious, progressive, immune-mediated kidney disease, as well as a leading cause of chronic kidney disease and kidney failure worldwide, according to Vera.Chief Executive Marshall Fordyce said Vera intends to submit a supplemental","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Vera Therapeutics Shares Gain on Positive Late-Stage Trial Results","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LU2324357040.USD","BK4585","VERA","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667439641","title":"Vera Therapeutics Reports Successful TRUTAKNA Phase 3 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2667439641","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667439641?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:17","pubTimestamp":1789471051,"startTime":"0","endTime":"0","summary":"Vera Therapeutics ( ($VERA) ) has shared an announcement. On September 15, 2026, Vera Therapeutics reported that TRUTAKNA met all prespecified endp...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vera-therapeutics-reports-successful-trutakna-phase-3-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vera-therapeutics-reports-successful-trutakna-phase-3-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2324357040.USD","BK4539","VERA","BK4588","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667641500","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2667641500","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667641500?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:12","pubTimestamp":1789470776,"startTime":"0","endTime":"0","summary":"Advasa  shares were up more than 49% in Tuesday's premarket activity, rebounding from a 58% loss in the previous session.Vera Therapeutics  stock was over 14% higher after the company said its kidney disease drug met all prespecified endpoints in a phase 3 trial final efficacy analysis.Radiant Logistics  shares were up 13% after the company reported higher fiscal Q4 adjusted earnings and revenue.Editas Medicine  stock was 9% higher after a 1.5% advance in the prior day's session.Eltek  shares were up 7%, extending Monday's 10% rise.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RLGT","EDIT","BK4131","BK4148","LU2324357040.USD","BK4023","BK4556","ADBT","VERA","BK4588","BK4139","ELTK","BK4585","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152096556","title":"Crypto Equities Slide Ahead of Pivotal Senate Vote on Market Structure Bill","url":"https://stock-news.laohu8.com/highlight/detail?id=1152096556","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152096556?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:11","pubTimestamp":1789470675,"startTime":"0","endTime":"0","summary":"Shares of cryptocurrency-related companies are trading lower in Tuesday's pre-market session, with Circle Internet Corp (CRCL.US) and Coinbase Global, Inc (COIN.US) each falling more than 5%. The...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COIN","LU0106831901.USD","BK4554","COIA","COIG","CONL","CIR","BITQ","BKCH","COII","LU1861558580.USD","07311","BK4600","BK4595","LU1791807156.HKD","LU1861559042.SGD","CCUP","09311","CONY","BK4535","BK4112","FINX","CONI","07711","COIX","CRCA","LU1668664300.SGD","LU1861217088.USD","BK4588","CRCO","BK4023","BK4516","LU2360107671.USD","FIAT","BK4596","IBLC","BK4585","09711","BLCK","ICRC","COYY","BK4539","CONX","CRPT","CRCG","BK4551","COIW","LU1861220207.SGD","COIO","ICOI","CRCD","FDIG","CRCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667641487","title":"Vera Therapeutics up 13% in pre-market at $38.63 after trutakna ORIGIN 3 data","url":"https://stock-news.laohu8.com/highlight/detail?id=2667641487","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667641487?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:11","pubTimestamp":1789470660,"startTime":"0","endTime":"0","summary":"07:05 EDT Vera Therapeutics (VERA) up 13% in pre-market at $38.63 after trutakna ORIGIN 3 data Published first on TheFly – the ultimate source for ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vera-therapeutics-up-13-in-pre-market-at-38-63-after-trutakna-origin-3-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vera-therapeutics-up-13-in-pre-market-at-38-63-after-trutakna-origin-3-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU2324357040.USD","BK4585","VERA","BK4588","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667418686","title":"Vera Therapeutics Gains After Kidney Disease Drug Meets Goals in Confirmatory Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2667418686","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667418686?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:03","pubTimestamp":1789470213,"startTime":"0","endTime":"0","summary":"BUZZ-Vera Therapeutics gains after kidney disease drug meets goals in confirmatory trial** Shares of Vera TherapeuticsVERA.Orise 11.6% to $38 premarket** Company says its drug Trutakna has met all goa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4N4570R9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","BK4139","BK4585","VERA","BK4588","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667495586","title":"Vera Therapeutics’ trutakna meets all efficacy endpoints in IgAN trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2667495586","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667495586?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:41","pubTimestamp":1789468891,"startTime":"0","endTime":"0","summary":"Vera Therapeutics (VERA) announced that trutakna met all prespecified endpoints of the final efficacy analysis of the ORIGIN 3 trial in adults with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vera-therapeutics-trutakna-meets-all-efficacy-endpoints-in-igan-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vera-therapeutics-trutakna-meets-all-efficacy-endpoints-in-igan-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","BK4588","BK4585","LU2324357040.USD","VERA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667646227","title":"Vera Therapeutics, - Trutakna Demonstrates Favorable Safety Profile Generally Comparable to Placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2667646227","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667646227?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:30","pubTimestamp":1789468207,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4560RM:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","BK4585","BK4139","VERA","BK4588","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667462776","title":"Vera Therapeutics, - Plans to Submit Supplemental Bla to FDA for Full Approval in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2667462776","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667462776?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:30","pubTimestamp":1789468207,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4560RM:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VERA","BK4588","LU2324357040.USD","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667279646","title":"Vera Therapeutics Announces Trutakna™ (Atacicept-Vymj) Stabilized Egfr and Prevented Kidney Disease Progression Through Two Years in Origin 3 Final Efficacy Analysis in Iga Nephropathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2667279646","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667279646?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:30","pubTimestamp":1789468207,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4560RM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","BK4139","VERA","BK4585","BK4539","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667164627","title":"Vera Therapeutics, - Trutakna Meets All Prespecified Endpoints in Origin 3 Final Efficacy Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2667164627","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667164627?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:30","pubTimestamp":1789468207,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4560RM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","BK4588","VERA","BK4585","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667646922","title":"Citi ups Acumen target, opens ‘upside 90-day catalyst watch’","url":"https://stock-news.laohu8.com/highlight/detail?id=2667646922","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667646922?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:15","pubTimestamp":1789467340,"startTime":"0","endTime":"0","summary":"Citi analyst Geoff Meacham raised the firm’s price target on Acumen (ABOS) to $5 from $4 and keeps a Buy rating on the shares. Citi also added an “...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/citi-ups-acumen-target-opens-upside-90-day-catalyst-watch-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/citi-ups-acumen-target-opens-upside-90-day-catalyst-watch-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ABOS","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667645424","title":"AI Slowdown Debate Lifts Software Stocks as MNDY Jumps 10.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667645424","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667645424?lang=en_us&edition=fundamental","pubTime":"2026-09-15 17:46","pubTimestamp":1789465612,"startTime":"0","endTime":"0","summary":"Enterprise software stocks rallied Monday as investors considered an unusual question: Could slower AI development actually be good for software co...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ai-slowdown-debate-lifts-software-stocks-as-mndy-jumps-10-7?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ai-slowdown-debate-lifts-software-stocks-as-mndy-jumps-10-7?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4613","QTOC","AGIX","LU1720051108.HKD","BK4585","BK4539","QQH","VTHR","LU2065171402.SGD","LU2357305700.SGD","VGT","BK4588","MNDY","LU2065170008.USD","LU2065171311.SGD","IGPT","IGV","LU1548497426.USD","ARTY","AIPO","IGM","QQHG","CHAT","LU2065169927.USD","BK4097","LU1720051017.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667551643","title":"Agilon Health upgraded to Outperform from Market Perform at Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2667551643","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667551643?lang=en_us&edition=fundamental","pubTime":"2026-09-15 17:15","pubTimestamp":1789463728,"startTime":"0","endTime":"0","summary":"Bernstein analyst Lance Wilkes upgraded Agilon Health (AGL) to Outperform from Market Perform with a price target of $125, up from $86. The company...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/agilon-health-upgraded-to-outperform-from-market-perform-at-bernstein-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/agilon-health-upgraded-to-outperform-from-market-perform-at-bernstein-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","BK4539","AGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122735912","title":"Zhihu Completes Share Buyback Worth $160,100 on September 14","url":"https://stock-news.laohu8.com/highlight/detail?id=1122735912","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122735912?lang=en_us&edition=fundamental","pubTime":"2026-09-15 17:06","pubTimestamp":1789463182,"startTime":"0","endTime":"0","summary":"ZHIHU-W (02390) announced that it repurchased 165,800 of its shares on September 14, 2026, at a total cost of $160,100. The buyback price per share ranged between $0.95 and $0.9767.This strategic...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1095","HK0000252152.HKD","ZH","BK4509","02390","BK4539","HK0000252160.HKD","HK0000500386.USD","BK4077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667610277","title":"Crypto-Linked Stocks Fall as Bitcoin Slides Ahead of Clarity Act Vote, Fed Decision","url":"https://stock-news.laohu8.com/highlight/detail?id=2667610277","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667610277?lang=en_us&edition=fundamental","pubTime":"2026-09-15 16:43","pubTimestamp":1789461795,"startTime":"0","endTime":"0","summary":"BUZZ-Crypto-linked stocks fall as bitcoin slides ahead of Clarity Act vote, Fed decision** Shares of cryptocurrency and blockchain-related companies fall premarket** BitcoinBTC=falls nearly 3% ahead o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL6N4570GR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSTR","SBIT","MRAL","FIAT","COIW","MSII","BK4594","CBOJ","LU1861220207.SGD","07399","MSDD","09311","BFJL","LFGY","COIG","LU1861559042.SGD","BK4539","MST","3SMI.UK","COIX","EZBC","BK4595","RIOX","07799","LU1861217088.USD","BTC","BK4596","MSTX","DFII","BK4547","COIA","COYY","ARKB","BK4526","SMI3.UK","COII","LMI3.UK","XBTY","BITO","IBLC","ICOI","GBTC","MHX","LU1861558580.USD","BK4170","CONY","CBTO","BTC.USD.CC","MARO","BITQ","09711","BK4023","CBOY","BK4112","BETE","BITI","FBTC","CBOA","HUT","HODL","COIN","BLCK","CONI","BK4600","BK4585","FDIG","BRRR","BTRN","07711","BETH","BPI","09799","YBTC","BITU","SMST","BITB","CONL","IMST","CBOO","BITY","MSTY","DAPP","MSTC","MAAY","CONX","RIOT","CRPT","BK4551","07311","BK4516","BK4535","CBXO","BTCO","CAN","MTYY","IMRA","09399","LU2360107671.USD","RTYY","BCCC","MSTK","BTCL","MAXI","BFAP","MSTZ","COIO","CBTY","APED","MSOO","CBXA","CBTA","BAGY","BITX","FINX","MSTP","BTBT","MSTW","BTCZ","BKCH","BK4601","BTF","WNTR","BK4588","MARA","MSTY.UK","BLOX","BTCW","MNRS","BTCI","MSTU","BTCC","QBF","CBTJ","CBXJ","3LMI.UK","BK4554","DEFI","OWNB","WGMI","CBXY","IBIT","HUTG","MSST"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":43,"pageCount":7,"totalSize":854,"code":"91000000","status":"200"}]}}